- Antidiabetic drugs and nephroprotection2018 | First Faculty of Medicine
- Nephroprotective effects of selected antidiabetics2021 | Third Faculty of Medicine
- Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension2020 | Faculty of Medicine in Hradec Králové
- SGLT2 inhibitors and atherosclerosis in a background of effect of gliflozins and heart failure2021 | First Faculty of Medicine
- Protective Effect of Captopril, Olmesartan, Melatonin and Compound 21 on Doxorubicin-Induced Nephrotoxicity in Rats2013 | Faculty of Medicine in Hradec Králové
- New approaches to the treatment of type 2 diabetes mellitus2017 | First Faculty of Medicine
- Proteinuria in outpatient practice2011 | First Faculty of Medicine
- Contrast - associated acute kidney injury - up to date 20192019 | Faculty of Medicine in Pilsen
- Antihypertensive medication in type 2 diabetics2013 | First Faculty of Medicine
- Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress2021 | First Faculty of Medicine
- Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria2013 | First Faculty of Medicine, Third Faculty of Medicine
- New treatment options for chronic kidney disease - focused on SGLT2 inhibitors2021 | First Faculty of Medicine
- Sparsentan. Dual angiotensin II AT1 receptor blocker and endothelin ETA receptor antagonist, Treatment of focal segmental glomerulosclerosis, Treatment of IgA nephropathy2020 | First Faculty of Medicine
- Oral semaglutid in the therapy of type 2 diabetes mellitus2021 | First Faculty of Medicine
- Oral semaglutide in the treatment of type 2 diabetes2020 | First Faculty of Medicine
- Metformin - the medicine of the past, present and certainly of the future2019 | First Faculty of Medicine
- Treatment of diabetic nephropathy2009 | First Faculty of Medicine
- Linagliptin in the treatment of type 2 diabetes mellitus current status and perspectives2013 | First Faculty of Medicine
- Role of fixed combination of atorvastatin, perindo2016 | Faculty of Medicine in Pilsen
- Finerenone2023 | First Faculty of Medicine
- The position of SGLT2 inhibitors in current medicine2020 | First Faculty of Medicine
- Newer possibilities of slowing the development of chronic kidney disease and the role of dapagliflozin2022 | First Faculty of Medicine
- Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis2006 | First Faculty of Medicine, Third Faculty of Medicine
- The position of SGLT2 inhibitors in current medical practice - update 20222022 | First Faculty of Medicine
- Early proteinuria lowering by angiotensin-converting enzyme inhibition predicts renal survival in children with CKD2018 | Second Faculty of Medicine